Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection (Q41026303)

25 September 2017

title

Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection (English)

1 reference

25 September 2017

main subject

Staphylococcus aureus

1 reference

1 reference

10

Kathrin U Jansen

1 reference

25 September 2017

Ingrid L Scully

1

1 reference

25 September 2017

Yekaterina Timofeyeva

2

1 reference

25 September 2017

David Keeney

3

1 reference

25 September 2017

Yury V Matsuka

4

1 reference

25 September 2017

Elena Severina

5

1 reference

25 September 2017

Lisa K McNeil

6

1 reference

25 September 2017

Jasdeep Nanra

7

1 reference

25 September 2017

George Hu

8

1 reference

25 September 2017

Paul A Liberator

9

1 reference

25 September 2017

Annaliesa S Anderson

11

1 reference

25 September 2017

language of work or name

English

0 references

publication date

26 August 2015

1 reference

25 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

25 September 2017

volume

33

1 reference

25 September 2017

issue

41

1 reference

25 September 2017

page(s)

5452-5457

1 reference

Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

A Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Risk factors for prosthetic joint infection: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.08.029

10.1016/J.VACCINE.2015.08.029

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference